Which hedge funds own TSHA? TAYSHA GENE THERAPIES INC, Q2 2026 13F holders
47 tracked hedge funds disclosed a position in TSHA (TAYSHA GENE THERAPIES INC) in their Q2 2026 13F filings, worth $947.7m in total. The largest holder by portfolio weight is GordonMD Global Investments LP at 11.9% of its book. 17 opened a new position this quarter: MPM Bioimpact LLC, Diadema Partners LP, Persistent Asset Partners Ltd, Orbimed Advisors LLC. 10 exited: Superstring Capital Management LP, Deerfield Management Company, L.P., Scientech Research LLC.
- 47
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 17
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 10
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $86.2m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $18.1m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $948m
- Combined value Sum of the holders' reported positions in the security.
- 3.8%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Superstring Capital Management LP | 0.8% | $1.2m |
| Deerfield Management Company, L.P. | 0.1% | $12.2m |
| Scientech Research LLC | 0.08% | $94.0k |
| Catalyst Funds Management Pty Ltd | 0.01% | $67.5k |
| Point72 Asset Management, L.P. | 0.0% | $2.1m |
| Tudor Investment Corp ET AL | 0.0% | $642k |
| Renaissance Technologies LLC | 0.0% | $1.8m |
| Y-Intercept (Hong Kong) Ltd | 0.0% | $51.3k |
| Hudson Bay Capital Management LP | 0.0% | $48.0k |
| Quantbot Technologies LP | 0.0% | $2.3k |
Ownership over time
Who discovered TSHA first? Beta
The run: Q2 2023 → Q3 2023, +378%
| Octagon Capital Advisors LP high conviction | Q3 2023 | – | +7.1 pts |
| RA Capital Management, L.P. | Q3 2023 | – | +1.1 pts |
| RTW Investments, LP | Q3 2023 | – | +0.9 pts |
| Diametric Capital, LP | Q3 2023 | – | −0.4 pts |
| Venrock Adviser, LLC | Q3 2023 | – | −1.9 pts |
| Kynam Capital Management, LP | Q3 2023 | – | – |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.